Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2016 Jan 13;160:135–142. doi: 10.1016/j.drugalcdep.2015.12.036

Table 2.

Adherence and primary outcomes by treatment condition

Placebo/
no CM1
Disulfiram /
no CM
Placebo/ CM Disulfiram/
CM
TOTAL Disulfiram CM Disulfiram
by CM
Variable n=26 n=28 n=22 n=23 n=99
mean sd mean sd mean sd mea
n
sd mea
n
sd F p F p F p
Treatment adherence
indicators
 Days retained in treatment
  protocol2
24.9 31.0 43.1 37.5 36.7 33.4 43.2 35.7 36.9 34.9 3.13 .08 0.73 .40 0.70 .40
 Mean percent days
  compliant with study
  medication
90.4 12.5 87.3 15.8 89.2 18.6 88.4 11.8 88.7 14.7 0.33 .57 0.00 .98 0.11 .74
 Percent treatment days of
  abstinence from alcohol,
  self-report
91.6 16.7 88.1 23.0 93.4 21.5 90.0 23.1 90.6 20.9 0.58 .45 0.16 .69 0.00 .99
Primary outcome
 Percent treatment days
  abstinence from
  cocaine-self report
72.2 27.3 79.2 18.1 91.1 13.6 69.6 31.7 77.8 24.4 2.02 .16 0.85 .36 7.84 .01
Secondary outcomes
 Percent cocaine-negative
  urines submitted3
28.7 36.8 39.5 40.8 60.5 35.3 41.2 40.3 43.1 39.3 0.08 .79 4.74 .03 2.19 .14
 Percent of participants
  abstinent three or more
  continuous weeks
  (number, %)
2 8.7% 7 25% 9 40.9% 6 26.1% 24 24.2
%
1.10 .30 0.01 .93 3.7 .05